Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea

ABSTRACT: The main objective of this study will be to obtain data on the efficacy of elsiglutide in preventing Chemotherapy Induced Diarrhea (CID) in patients with colorectal cancer receiving 5-FU based chemotherapy (FOLFOX4 or FOLFIRI regimen) in comparison to placebo.

DISEASE(S): Kemoterápia Okozta Hasmenés,Chemotherapy Induced Diarrhea,Diarrhea Post Chemotherapy,Diarrhea

PROVIDER: 2121148 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR